Viveon Health Acquisition... (VHAQ)
AMEX: VHAQ
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Jan 30, 2025, 9:00 PM
Viveon Health Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 268.67K | 98.89K | 203.07K | 170.73K | 283.69K | 1.05M | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -268.67K | -98.89K | -203.07K | -170.73K | -283.69K | -1.05M | n/a | n/a | n/a |
Operating Income | n/a | n/a | -595.82K | 281.53K | -939.77K | -639.35K | -1.07M | -2.35M | -678.62K | -2.1M | -335.32K |
Interest Income | n/a | n/a | n/a | 415.87K | 230.63K | 65.7K | 12.93K | 5.13K | 5.15K | 5.1K | 5.09K |
Pretax Income | n/a | n/a | 163.43K | 3.01M | -2.38M | 474.28K | -1.52M | -1.86M | 1.18M | -409.15K | 3.58M |
Net Income | n/a | n/a | 262.93K | 2.95M | -2.38M | 474.28K | -1.52M | -1.86M | 1.18M | -409.15K | 3.58M |
Selling & General & Admin | n/a | n/a | 301.39K | -513.28K | 703.83K | 436.11K | 742.04K | 1.1M | 788.69K | 648.12K | 321.43K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | 231.75K | 235.94K | 203.24K | 331.67K | 1.25M | n/a | n/a | n/a |
Operating Expenses | n/a | n/a | 301.39K | 132.86K | 939.77K | 639.35K | 1.07M | 2.35M | 788.69K | 648.12K | 321.43K |
Interest Expense | n/a | n/a | n/a | 2.55M | 737.93K | 259.75K | 99.54K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | n/a | 570.06K | 132.86K | 939.77K | 639.35K | 1.07M | 2.35M | 788.69K | 1.87M | 321.43K |
Income Tax Expense | n/a | n/a | -99.5K | 61.31K | n/a | n/a | n/a | n/a | -110.07K | 1.45M | 13.89K |
Shares Outstanding (Basic) | 5.87M | 5.87M | 5.87M | 12.22M | 9.06M | 9.06M | 21.97M | 25.16M | 24.15M | 24.15M | 24.15M |
Shares Outstanding (Diluted) | 5.87M | 5.87M | 5.87M | 12.22M | 9.06M | 9.06M | 21.97M | 25.16M | 24.15M | 24.15M | 24.15M |
EPS (Basic) | n/a | n/a | 0.04 | 0.43 | -0.26 | 0.05 | -0.07 | -0.09 | 0.05 | -0.08 | 0.15 |
EPS (Diluted) | n/a | n/a | 0.04 | 0.43 | -0.26 | 0.05 | -0.07 | -0.08 | 0.05 | -0.08 | 0.15 |
EBITDA | n/a | n/a | -595.82K | 5.56M | -1.45M | 734.03K | -1.42M | -2.35M | 1.29M | -1.86M | 3.9M |
EBIT | n/a | n/a | n/a | 5.56M | -1.65M | 734.03K | -1.42M | -2.35M | 1.29M | -1.86M | 3.57M |
Depreciation & Amortization | -39.59K | 122.08K | n/a | n/a | 201.84K | n/a | n/a | n/a | n/a | n/a | 335.32K |